Hologic granted FDA Emergency Use Authorization for asymptomatic COVID-19 testing with Panther Fusion SARS-CoV-2 assay
On Sept. 28, 2020, Hologic announced that its Panther Fusionﾮ SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
-
-
DOD and HHS awarded $20 million contract to On Demand Pharmaceuticals to develop critical pharmaceutical ingredients
On Sept. 28, 2020, the U.S. Departments of Defense and Health and Human Services signed a $20 million…
-
ViroVax licensed adjuvant to be used in India’s first COVID-19 vaccine in human trials
On Sept. 28 2020, ViroVax announced that it had licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International, an…
-
CDC | COVID-19 | Diagnostics | Non-Profit Research | WHO
Global partnership made available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries
On Sept. 28, 2020, the World Health Organization announced agreements to make available, for low and middle-income countries,…
-
About 14% of cerebral palsy cases may be tied to brain wiring genes
On Sept. 28, 2020, in an article published in Nature Genetics, researchers confirmed that about 14% of all…
-
NIH-funded study shed light on abnormal neural function in rare genetic disorder
On Sept. 28, 2020, a genetic study identified neuronal abnormalities in the electrical activity of cortical cells derived…
-
Regular COVID-19 testing for groups most likely to spread the virus more efficient, cost-effective than random testing
On Sept. 28, 2020, as COVID-19 infections began to rise again, a novel testing strategy was proposed by…
-
Immunic announced results from interim safety analysis from ongoing phase 2 CALVID-1 trial of IMU-838 in patients with COVID-19
On Sept. 28, 2020, Immunic announced the results of a pre-planned interim safety analysis and a recruitment update…
-
Tonix Pharma completed the purchase of a facility to house advanced development center for vaccine programs
On Sept. 28, 2020, Tonix Pharmaceuticals announced that it had completed the purchase a 40,000 square foot facility…
-
OpGen announced completion of study collaboration with Karolinska Institutet on bacterial co-infections in COVID-19 pneumonia patients
On Sept. 28, 2020, OpGen announced the successful completion of the clinical study between its subsidiary, Curetis, and…
-
Biotechnology | COVID-19 | FDA | Infectious Disease | NIH | Vaccine
INOVIO reported FDA partial clinical hold for planned phase 2/3 trial of COVID-19 vaccine candidate INO-4800
On Sept. 28, 2020, INOVIO announced the U.S. Food and Drug Administration (FDA) had notified the company that…
-
Evaluation of LamPORE rapid tests for Covid-19 showed high levels of diagnostic sensitivity
On Sept. 25, 2020, scientists from the University of Oxfordﾒs Nuffield Department of Medicine published their evaluation of…
-
Todos Medical entered Into COVID-19 PCR testing implementation and equipment financing partnership with AID Genomics
On Sept. 25, 2020, Todos Medical announced that it had entered into an implementation and equipment financing partnership…
-
CDC’s ACIP recommended routine vaccination with a quadrivalent meningococcal conjugate vaccine for adolescents aged 11 or 12 years, with a booster dose at age 16 years.
On Sept. 25, 2020, the Advisory Committee on Immunization Practices (ACIP) recommended routine vaccination with a quadrivalent meningococcal…
-
Novavax initiated phase 3 efficacy trial of COVID-19 vaccine in the UK
On Sept. 24, 2020, Novavax announced that it had initiated its first Phase 3 study to evaluate the…
-
Human heart mapped cell by cell
On Sept. 24, 2020, a team of scientists announced they had created the first atlas of human heart…
-
Scientists discovered genetic and immunologic underpinnings of some cases of severe COVID-19
On Sept. 24, 2020, new findings reported by scientists at the National Institutes of Health and their collaborators…
-
Y chromosomes of Neandertals and Denisovans was sequenced
On Sept. 24, 2020, an international research team led by the Max Planck Institute for Evolutionary Anthropology in…
-
Lumen Bioscience awarded Federal grant to rapidly develop antibody-based Covid-19 therapeutic
On Sept. 24, 2020, Lumen Bioscience and the US Army Medical Research and Development Command, announced an agreement…
-
Yale designated labs in three states to provide SalivaDirect COVID-19 test
On Sept. 24, 2020, Yale University announced it had designated three independent laboratories to perform the university-developed SalivaDirect…
-
FDA took actions to help lower US prescription drug prices
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…
-
Fourth large-scale COVID-19 vaccine trial began in the United States
On Sept. 23, 2020, a fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019…
-
Sinovacﾒs Coronavacﾙ, SARS-CoV-2 vaccine, inactivated, announced approval for phase I/II clinical trial in adolescents and children
On Sept. 23, 2020, Sinovac Biotech announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences,…
-
Countries urged to take stronger action to stop spread of harmful COVID-19 pandemic information
On Sept. 23, 2020, the WHO with the UN, specialised agencies and partners called on countries to develop…
-
USDA study revealed airborne fungus can trigger plant growth
On Sept. 23, 2020, the USDA Agricultural Research Service (ARS) announced that a harmless airborne fungus, Cladosporium sphaerospermum…
-
Johnson & Johnson initiated pivotal global phase 3 clinical trial of Janssen’s COVID-19 vaccine candidate
On Sept. 23, 2020, Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial…
-
US Cruise ship no sail order extended through October 31, 2020
On Sept. 23, 2020, the CDC announced the extension of a No Sail Order for cruise ships through…
-
FDA authorized first point-of-care antibody test for COVID-19
On Sept. 23, 2020, the FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care…
-
Pascal Biosciences confirmed specific cannabinoids combat Coronavirus
On Sept. 23, 2020, Pascal Biosciences announced the Company had confirmed an earlier report that certain cannabinoids block…
-
CDC provided $200 million to jurisdictions for COVID-19 vaccine preparedness
On Sept. 23, 2020, the CDC awarded $200 million to 64 jurisdictions through the existing Immunizations and Vaccines…
